AllianceBernstein’s BioSpecifics Technologies Corp. BSTC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-8,700
| Closed | -$460K | – | 3240 |
|
|
2020
Q3 | $460K | Hold |
8,700
| – | – | ﹤0.01% | 2564 |
|
|
2020
Q2 | $533K | Buy |
8,700
+900
| +12% | +$52.1K | ﹤0.01% | 2573 |
|
|
2020
Q1 | $441K | Buy |
7,800
+700
| +10% | +$39.9K | ﹤0.01% | 2416 |
|
|
2019
Q4 | $404K | Hold |
7,100
| – | – | ﹤0.01% | 2637 |
|
|
2019
Q3 | $380K | Buy |
7,100
+1,200
| +20% | +$69.9K | ﹤0.01% | 2691 |
|
|
2019
Q2 | $352K | Sell |
5,900
-200
| -3% | -$12.6K | ﹤0.01% | 2764 |
|
|
2019
Q1 | $380K | Hold |
6,100
| – | – | ﹤0.01% | 2647 |
|
|
2018
Q4 | $370K | Buy |
6,100
+1,300
| +27% | +$77.7K | ﹤0.01% | 2614 |
|
|
2018
Q3 | $281K | Buy |
+4,800
| New | +$245K | ﹤0.01% | 2879 |
|
|
2017
Q4 | – | Sell |
-17,070
| Closed | -$794K | – | 3101 |
|
|
2017
Q3 | $794K | Sell |
17,070
-6,350
| -27% | -$304K | ﹤0.01% | 2388 |
|
|
2017
Q2 | $1.16M | Sell |
23,420
-17,400
| -43% | -$911K | ﹤0.01% | 2215 |
|
|
2017
Q1 | $2.24M | Buy |
40,820
+32,685
| +402% | +$1.73M | ﹤0.01% | 1730 |
|
|
2016
Q4 | $453K | Buy |
+8,135
| New | +$391K | ﹤0.01% | 2595 |
|
|
2015
Q2 | – | Sell |
-800
| Closed | -$31K | – | 3364 |
|
|
2015
Q1 | $31K | Buy |
800
+400
| +100% | +$15.7K | ﹤0.01% | 3200 |
|
|
2014
Q4 | $15K | Hold |
400
| – | – | ﹤0.01% | 3268 |
|
|
2014
Q3 | $14K | Sell |
400
-400
| -50% | -$11.7K | ﹤0.01% | 3248 |
|
|
2014
Q2 | $22K | Buy |
800
+691
| +634% | +$18K | ﹤0.01% | 3224 |
|
|
2014
Q1 | $3K | Hold |
109
| – | – | ﹤0.01% | 3389 |
|
|
2013
Q4 | $2K | Hold |
109
| – | – | ﹤0.01% | 3270 |
|
|
2013
Q3 | $2K | Buy |
109
+29
| +36% | +$514 | ﹤0.01% | 3290 |
|
|
2013
Q2 | $1K | Buy |
+80
| New | +$1.29K | ﹤0.01% | 3236 |
|
Other funds holding BSTC
AllianceBernstein's BSTC Position: Q4 2020 in Review
AllianceBernstein sold out of BioSpecifics Technologies Corp. (BSTC) in Q4 2020, closing a stake of 8,700 shares — an estimated $460K sold.
AllianceBernstein first reported a position in BSTC in Q2 2013 and held it in 21 quarters. The position peaked at $2.24M in Q1 2017. 1 fund tracked by Wall St. Rank holds BSTC as of Q4 2020.
- AllianceBernstein reported no remaining BioSpecifics Technologies Corp. position as of Q4 2020 after selling out during the quarter.
- AllianceBernstein sold 8,700 BioSpecifics Technologies Corp. shares in Q4 2020, an estimated $460K.
- AllianceBernstein first reported a position in BioSpecifics Technologies Corp. in Q2 2013 and held it in 21 quarters.
- AllianceBernstein's BioSpecifics Technologies Corp. position peaked at $2.24M in Q1 2017.
- 1 fund tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q4 2020.
Based on AllianceBernstein's 13F filing for Q4 2020, filed 8 Feb 2021.